Maravai LifeSciences (MRVI) Financials: Revenue & Earnings
MRVI$8.35+0.09 +1.09%
$2.37B
Market Cap
-15.31
P/E
—
Forward P/E
46
Score
Maravai LifeSciences (MRVI) Financials: Revenue & Earnings
MRVI price $8.35 +0.09 +1.09%
- Ticker
- MRVI
- Price
- $8.35
- Change
- +0.09 +1.09%
- Market cap ?
- $2.37B
- P/E ?
- -15.31
- Dividend yield ?
- 0.00%
- Beta ?
- 0.60
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 46
- Value
- 53
- Quality
- 70
- Growth
- 16
Stocklytics score rationale: value 53, quality 70, growth 16.
Financials
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 123833000 | 143140000 | 284098000 | 799240000 | 883001000 | 288945000 | 259185000 | 185743000 |
Maravai LifeSciences Holdings, Inc. is a life sciences company operating globally, supplying essential products that facilitate the advancement of drug therapies, diagnostics, innovative vaccines, and research into human diseases. Its diverse product line supports critical stages of biopharmaceutical development, featuring nucleic acids for both diagnostic and therapeutic applications, antibody-based solutions for…
Fair value
MRVI fair value $42.64. Price $8.35. Price is 80% below fair value.
Below fair value, but more expensive than usual. A smaller discount than on 68% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 82.20M. Growth 14.04%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 148.99M. Net debt -181.31M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-04 | — | -0.06 | — | 43.56M |
| 2026-08-06 | -0.02 | -0.04 | 51.44M | 48.67M |
| 2026-05-07 | 0.01 | -0.05 | 65.84M | 53.00M |
| 2026-02-25 | -0.04 | -0.07 | 49.87M | 49.05M |
| 2025-11-06 | -0.08 | -0.06 | 41.63M | 49.06M |
| 2025-08-11 | -0.08 | -0.06 | 47.40M | 50.08M |
| 2025-05-12 | -0.08 | -0.07 | 46.85M | 44.01M |
| 2025-03-18 | -0.06 | -0.03 | 56.41M | 57.79M |
| 2024-11-07 | -0.02 | -0.01 | 65.20M | 56.64M |
| 2024-08-07 | -0.08 | -0.04 | 73.40M | 71.63M |
| 2024-05-08 | -0.02 | -0.02 | 64.18M | 60.55M |
| 2024-02-22 | 0.01 | 0.00 | 74.14M | 64.38M |
| 2023-11-07 | -0.01 | -0.00 | 66.86M | 75.52M |
| 2023-08-07 | -0.06 | -0.03 | 68.91M | 71.13M |
| 2023-05-08 | 0.03 | 0.04 | 79.03M | 79.72M |
| 2023-02-22 | 0.35 | 0.34 | 204.71M | 204.93M |
| 2022-11-02 | 0.37 | 0.32 | 191.26M | 195.11M |
| 2022-08-04 | 0.54 | 0.45 | 242.73M | 233.22M |
| 2022-05-05 | 0.54 | 0.44 | 244.29M | 232.29M |
| 2022-02-23 | 0.45 | 0.38 | 228.44M | 208.09M |
| 2021-11-10 | 0.44 | 0.35 | 204.81M | 152.14M |
| 2021-08-10 | 0.44 | 0.32 | 217.78M | 194.81M |
| 2021-05-10 | 0.26 | 0.21 | 148.21M | 112.92M |
| 2021-03-02 | 0.13 | 0.12 | 98.35M | — |
| 2020-11-23 | 0.00 | — | 46.91M | — |
| 2020-09-30 | 0.44 | — | 87.86M | — |
| 2020-03-31 | 0.26 | — | 50.98M | — |
| 2019-12-31 | -0.06 | — | 35.96M | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-08 | Brust Bernd | Sell | 29.25K | $7.43 | 217.33K |
| 2026-09-30 | Asarpota Rajesh | Sell | 5.46K | $7.65 | 41.81K |
| 2026-09-08 | Brust Bernd | Sell | 29.25K | $7.32 | 214.11K |
| 2026-08-31 | Asarpota Rajesh | Sell | 5.46K | $7.68 | 41.97K |
| 2026-08-10 | Brust Bernd | Sell | 29.25K | $6.23 | 182.23K |
| 2026-07-30 | Asarpota Rajesh | Sell | 5.46K | $6.59 | 36.01K |
| 2026-07-08 | Brust Bernd | Sell | 29.25K | $5.92 | 173.16K |
| 2026-06-30 | Asarpota Rajesh | Sell | 65.58K | $6.39 | 419.08K |
| 2026-06-10 | ORESHACK KURT | Sell | 25.00K | $5.10 | 127.50K |
| 2026-06-09 | ORESHACK KURT | Sell | 25.00K | $5.06 | 126.50K |
| 2026-06-09 | LUCIER GREGORY T | Buy | 46.29K | — | — |
| 2026-06-09 | LUCIER GREGORY T | Sell | 46.29K | — | — |
| 2026-06-08 | Brust Bernd | Sell | 351.00K | $5.02 | 1.76M |
| 2026-05-26 | LUCIER GREGORY T | Buy | 46.29K | — | — |
| 2026-05-26 | MARKER LUKE JOSEPH | Buy | 46.29K | — | — |
| 2026-05-26 | GRAY SUSANNAH | Buy | 46.29K | — | — |
| 2026-05-26 | MIHAS CONSTANTINE S | Buy | 46.29K | — | — |
| 2026-05-26 | ECKERT R ANDREW | Buy | 46.29K | — | — |
| 2026-05-26 | LUCIER GREGORY T | Buy | 46.29K | $4.38 | 202.76K |
| 2026-05-26 | CUNNINGHAM SEAN LAURENCE | Buy | 46.29K | — | — |
| 2026-05-26 | DeFord John A | Buy | 46.29K | — | — |
| 2026-05-15 | Dolan Christine | Buy | 5.01K | $1.79 | 8.96K |
| 2026-05-15 | ORESHACK KURT | Buy | 776 | $2.84 | 2.20K |
| 2026-03-16 | Dolan Christine | Sell | 28.66K | $3.08 | 88.28K |
| 2026-03-16 | ORESHACK KURT | Sell | 39.98K | $3.08 | 123.13K |
| 2026-01-15 | Dolan Christine | Sell | 28.93K | $3.69 | 106.77K |
| 2026-01-15 | ORESHACK KURT | Sell | 31.90K | $3.69 | 117.72K |
| 2025-12-08 | LUCIER GREGORY T | Buy | 48.53K | $3.67 | 178.10K |
| 2025-12-05 | LUCIER GREGORY T | Buy | 51.47K | $3.70 | 190.45K |
| 2025-11-14 | Dolan Christine | Buy | 4.30K | $1.79 | 7.70K |
| 2025-11-13 | Brust Bernd | Buy | 216.21K | $3.25 | 702.69K |
| 2025-11-12 | Brust Bernd | Buy | 93.36K | $3.21 | 299.68K |
| 2025-11-11 | Brust Bernd | Buy | 157.20K | $3.24 | 509.33K |
| 2025-07-15 | Leddy Peter Michael | Sell | 5.15K | $2.59 | 13.35K |
| 2025-07-10 | LUCIER GREGORY T | Buy | 89.14K | — | — |
| 2025-07-10 | LUCIER GREGORY T | Sell | 89.14K | — | — |
| 2025-06-30 | Asarpota Rajesh | Buy | 750.00K | — | — |
| 2025-06-30 | Asarpota Rajesh | Buy | 500.00K | — | — |
| 2025-06-30 | Asarpota Rajesh | Buy | 333.33K | $2.41 | 803.33K |
| 2025-06-30 | Asarpota Rajesh | Other | 0 | — | — |
| 2025-06-16 | DAVERMAN BENJAMIN JAMES | Buy | 89.14K | $2.16 | 192.54K |
| 2025-06-16 | GRAY SUSANNAH | Buy | 89.14K | $2.16 | 192.54K |
| 2025-06-16 | MARKER LUKE JOSEPH | Buy | 89.14K | $2.16 | 192.54K |
| 2025-06-16 | LUCIER GREGORY T | Buy | 89.14K | $2.16 | 192.54K |
| 2025-06-16 | PRAHALAD MURALI | Buy | 89.14K | $2.16 | 192.54K |
| 2025-06-16 | CUNNINGHAM SEAN LAURENCE | Buy | 89.14K | $2.16 | 192.54K |
| 2025-06-16 | ECKERT R ANDREW | Buy | 231.48K | $2.16 | 500.00K |
| 2025-06-16 | MIHAS CONSTANTINE S | Buy | 89.14K | $2.16 | 192.54K |
| 2025-06-16 | Hopfield Jessica | Buy | 89.14K | $2.16 | 192.54K |
| 2025-06-16 | DeFord John A | Buy | 89.14K | $2.16 | 192.54K |
| 2025-06-08 | Brust Bernd | Buy | 2.25M | — | — |
| 2025-06-08 | Brust Bernd | Buy | 2.00M | — | — |
| 2025-06-08 | Brust Bernd | Buy | 1.00M | $2.39 | 2.39M |
| 2025-06-08 | Brust Bernd | Other | 0 | — | — |
| 2025-05-15 | Herde Kevin | Buy | 876 | $1.67 | 1.46K |
| 2025-05-15 | Dolan Christine | Buy | 2.38K | $1.67 | 3.98K |
| 2025-03-17 | Herde Kevin | Buy | 394.48K | — | — |
| 2025-03-17 | ORESHACK KURT | Buy | 295.86K | — | — |
| 2025-03-17 | BUZZEO REBECCA | Buy | 295.86K | — | — |
| 2025-03-17 | Leddy Peter Michael | Buy | 394.48K | — | — |
| 2025-03-17 | MARTIN WILLIAM E. III | Buy | 986.19K | — | — |
| 2025-03-17 | Dolan Christine | Buy | 246.55K | — | — |
| 2025-03-17 | Herde Kevin | Sell | 8.65K | $2.64 | 22.83K |
| 2025-03-17 | Leddy Peter Michael | Sell | 5.89K | $2.64 | 15.54K |
| 2025-03-17 | ORESHACK KURT | Sell | 4.58K | $2.64 | 12.09K |
| 2025-03-17 | Dolan Christine | Sell | 5.34K | $2.64 | 14.09K |
| 2025-03-17 | BUZZEO REBECCA | Sell | 4.31K | $2.64 | 11.39K |
| 2025-02-18 | ORESHACK KURT | Sell | 2.03K | $4.10 | 8.31K |
| 2025-02-18 | Dolan Christine | Sell | 1.62K | $4.10 | 6.65K |
| 2025-02-18 | Herde Kevin | Sell | 2.33K | $4.10 | 9.54K |
| 2025-01-31 | ORESHACK KURT | Sell | 25.00K | $5.03 | 125.75K |
| 2025-01-15 | MARTIN WILLIAM E. III | Sell | 160.98K | $4.56 | 734.07K |
| 2025-01-15 | Herde Kevin | Sell | 46.34K | $4.56 | 211.33K |
| 2025-01-15 | BURCH ANDREW | Sell | 54.41K | $4.56 | 248.12K |
| 2025-01-15 | BUZZEO REBECCA | Sell | 45.46K | $4.56 | 207.28K |
| 2025-01-15 | ORESHACK KURT | Sell | 31.44K | $4.56 | 143.36K |
| 2025-01-15 | Dolan Christine | Sell | 28.70K | $4.56 | 130.89K |
| 2025-01-15 | Leddy Peter Michael | Sell | 32.04K | $4.56 | 146.11K |
| 2024-12-16 | ECKERT R ANDREW | Buy | 134.41K | — | — |
| 2024-12-09 | LUCIER GREGORY T | Sell | 20.64K | — | — |
| 2024-12-09 | LUCIER GREGORY T | Buy | 20.64K | — | — |
| 2024-12-05 | ECKERT R ANDREW | Other | 0 | — | — |
| 2024-11-15 | BUZZEO REBECCA | Sell | 4.36K | $4.42 | 19.28K |
| 2024-11-12 | DeFord John A | Buy | 17.50K | $5.75 | 100.62K |
| 2024-11-11 | HULL CARL | Buy | 175.00K | $5.64 | 987.00K |
| 2024-10-31 | Herde Kevin | Buy | 1.91K | $5.70 | 10.86K |
| 2024-10-31 | ORESHACK KURT | Buy | 366 | $5.70 | 2.09K |
| 2024-10-31 | Dolan Christine | Buy | 1.85K | $5.70 | 10.53K |
| 2024-10-31 | BURCH ANDREW | Buy | 1.84K | $5.70 | 10.49K |
| 2024-10-15 | MARTIN WILLIAM E. III | Sell | 50.84K | $8.29 | 421.49K |
| 2024-07-15 | Leddy Peter Michael | Sell | 5.15K | $8.76 | 45.15K |
| 2024-05-28 | GTCR INVESTMENT XI LLC | Sell | 8.41M | — | — |
| 2024-05-28 | GTCR INVESTMENT XI LLC | Sell | 8.41M | $0.01 | 84.10K |
| 2024-05-28 | GTCR INVESTMENT XI LLC | Buy | 8.41M | $0.01 | 84.10K |
| 2024-05-28 | GTCR INVESTMENT XI LLC | Sell | 9.94M | $9.81 | 97.57M |
| 2024-05-23 | MIHAS CONSTANTINE S | Buy | 20.64K | $10.78 | 222.55K |
| 2024-05-23 | CUNNINGHAM SEAN LAURENCE | Buy | 20.64K | $10.78 | 222.55K |
| 2024-05-23 | PRAHALAD MURALI | Buy | 20.64K | $10.78 | 222.55K |
| 2024-05-23 | Ashkenazi Anat | Buy | 20.64K | $10.78 | 222.55K |
| 2024-05-23 | DAVERMAN BENJAMIN JAMES | Buy | 20.64K | $10.78 | 222.55K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 187, holders +22 vs prior quarter. Ownership 95.50%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| GTCR LLC | 20.15M | 0 | 0.00% | 125.74M |
| BLACKROCK, INC. | 9.97M | 625.51K | +6.69% | 62.22M |
| BRAIDWELL LP | 8.70M | -1.54M | -15.01% | 54.31M |
| 12 WEST CAPITAL MANAGEMENT LP | 7.06M | -200.00K | -2.75% | 44.06M |
| MILLENNIUM MANAGEMENT LLC | 6.51M | 4.86M | +294.56% | 40.61M |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.28M | -166.04K | -3.05% | 32.97M |
| OPHIR ASSET MANAGEMENT PTY LTD | 4.83M | 4.83M | New | 30.12M |
| RENAISSANCE TECHNOLOGIES LLC | 4.61M | 341.80K | +8.01% | 28.74M |
| DEUTSCHE BANK AG\ | 4.30M | 3.45M | +401.59% | 26.86M |
| FIRST EAGLE INVESTMENT MANAGEMENT, LLC | 3.67M | 1.15M | +45.44% | 22.91M |
| GEODE CAPITAL MANAGEMENT, LLC | 3.13M | 301.66K | +10.66% | 19.54M |
| STATE STREET CORP | 2.90M | 472.99K | +19.47% | 18.11M |
| NUVEEN, LLC | 2.86M | 2.63M | +1141.63% | 17.83M |
| JPMORGAN CHASE & CO | 2.59M | 2.24M | +625.96% | 16.57M |
| TWO SIGMA INVESTMENTS, LP | 2.26M | 675.98K | +42.79% | 14.08M |
| MONACO ASSET MANAGEMENT SAM | 2.23M | -1.19M | -34.78% | 13.92M |
| PRUDENTIAL FINANCIAL INC | 2.15M | 2.15M | New | 13.43M |
| CITADEL ADVISORS LLC | 2.12M | 2.07M | +4331.31% | 13.25M |
| POINT72 ASSET MANAGEMENT, L.P. | 2.01M | -1.20M | -37.43% | 12.51M |
| MORGAN STANLEY | 1.91M | -1.41M | -42.51% | 11.91M |
| PHILOSOPHY CAPITAL MANAGEMENT LLC | 1.90M | -737.12K | -27.95% | 11.86M |
| TUDOR INVESTMENT CORP ET AL | 1.85M | 1.45M | +365.86% | 11.54M |
| ROYCE & ASSOCIATES LP | 1.81M | 0 | 0.00% | 11.28M |
| GENERAL AMERICAN INVESTORS CO INC | 1.72M | 0 | 0.00% | 10.71M |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 1.68M | 1.68M | New | 10.50M |
Earnings and financials
Maravai LifeSciences Holdings, Inc. (MRVI) trades at $8.35, with a market cap of $2.37B and a trailing P/E of -15.31. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 123833000 | 143140000 | 284098000 | 799240000 | 883001000 | 288945000 | 259185000 | 185743000 |
Insights · Dividends · Forecast · Financials · Learn